Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/21/2013 | 11:03am CEST

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: [email protected]

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

[email protected]

Sheryl Seapy

Pure Communications

[email protected]


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
01:55p UNION PACIFIC : A train ride back in time
01:54p BANQUE SAUDI FRANSI : announces the results of shareholder Ordinary general assembly meeting
01:53p SONY : to launch high-speed, silent mirrorless camera
01:53p JOHN WOOD : Artemis Investment Management LLP Form 8.3 - Wood Group (John)PLC
01:48p OMANI QATARI TELECOMMUNICATIONS SAOG : Ooredoo To Expand Superfast Fibre Coverage to Three Additional Areas in Muscat Governorate
01:46p FINTECH : Is Islamic finance ready for disruption?
01:46p FEDERAL NATIONAL MORTGAGE ASSCTN FNNI ME : Local mortgage servicing company continues expanding
01:43p EAT WELL LIVEWELL : No Bake Granola Bars
01:41p LAFARGEHOLCIM : CEO to step down over Syria controversy - FT
01:26p SAVS BANK : Methuen police arrest bank robbery suspect
Latest news
Advertisement
Hot News 
6.39%Struggling apparel retailer Bebe to shut all stores
2.67%Honeywell profit beats as aerospace, energy businesses deliver
-2.38%AHEAD OF THE TAPE : General Electric Is Overdue for Good News -- WSJ
-3.06%BAKER HUGHES INCORPORATED : U.S. Oil-Rig Count Rises by 5
-2.40%Verizon Customers Defect As Competition Ramps Up -- WSJ
Most Read News
04/22 UNITED CONTINENTAL : American Airlines employee suspended after clash with traveller in San Francisco
04/22 MANCHESTER UNITED : face Celta Vigo, Ajax meet Lyon in last four
02:13a BAYERISCHE MOTOREN WERKE : BMW reveals i8 Protonic special edition
04:18a DOHA BANK : knowledge session dwells on GCC, global economic trends
04/22 RALPH LAUREN : to shut down Fifth Avenue Polo store
Most recommended articles
04/21 TWENTY FIRST CENTURY FOX : Government extends period for regulators to report on Sky-Fox merger
04/17DJABBOTT LABORATORIES : Cyber Insurance Becomes a Must for More Manufacturers
07:41a LAFARGEHOLCIM : CEO to step down over Syria controversy - FT
07:15aDJIndexing Pivotal in S&P Global's Rebound From Crisis Scandal
07:15aDJWAL MART STORES : Three Hard Lessons the Internet Is Teaching Traditional Stores